No results for ‘’
Sun Pharmaceutical Industries Ltd
₹1792.50
(0.34%)
Sun, 14 Jun 2026, 06:11 am
Health Technology
Pharmaceuticals: Major
24.5KSun Pharmaceutical Industries Share Price Live Chart
1 Day
(0.34%)
No Result Found
Summary
Market Cap (in Cr)
432096.23
Net Profit (in Cr)
10980.1
P/B
5.77
Sector P/E
33.76
P/E
38.10
EV/EBITDA
24.60
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
16.16
ROCE
19.52
Debt/Equity
0.04
EPS (TTM)
52.01
Dividend Yield
0.89
Book Value
348.31
Interest Cover
60.44
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (3.9x coverage).
- Dividends after 3 years are expected to be well covered by earnings (6.3x coverage).
- Sun Pharmaceutical Industries's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Sun Pharmaceutical Industries's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Sun Pharmaceutical Industries's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Sun Pharmaceutical Industries is expected to increase but not above the 50% threshold in 2 years time.
- Sun Pharmaceutical Industries's earnings are expected to grow by 17.5% yearly, however this is not considered high growth (20% yearly).
- Sun Pharmaceutical Industries's earnings growth is positive but not above the India market average.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 54.48 | 54.48 | 54.48 | 54.48 | 54.48 |
| FII | 15.94 | 16.12 | 16.55 | 17.26 | 17.96 |
| DII | 21.11 | 20.82 | 20.23 | 19.50 | 18.70 |
| Public | 8.48 | 8.58 | 8.73 | 8.77 | 8.87 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2096.30 | 1965.00 | 1882.10 | 1833.70 | 1750.80 | 1702.40 | 1571.10 |
| Fibonacci | 1965.00 | 1914.84 | 1883.86 | 1833.70 | 1783.54 | 1752.56 | 1702.40 |
| Camarilla | 1835.31 | 1823.27 | 1811.24 | 1833.70 | 1787.16 | 1775.13 | 1763.09 |
Pivots Level: Classic
R3
+262.60
2096.30
R2
+131.30
1965.00
R1
+48.40
1882.10
S1
-82.90
1750.80
S2
-131.30
1702.40
S3
-262.60
1571.10
Moving Average
Period
Value
10-EMA
1798.40
20-EMA
1805.28
30-EMA
1802.83
50-EMA
1791.46
100-EMA
1767.86
200-EMA
1742.06
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 22 May 2026 | board-meetings | Accounts, Final Dividend | |
| 31 Jan 2026 | dividend | ₹11.00 Dividend /Share | 05 Feb 2026 |
| 31 Jan 2026 | board-meetings | Quarterly Results, Interim Dividend | |
| 05 Jan 2026 | dividend | Interim Dividend - Rs. - 11 | 05 Feb 2026 |
| 05 Nov 2025 | board-meetings | Quarterly Results | |
| 07 Jun 2025 | dividend | Final Dividend - Rs. - 5.5 | 07 Jul 2025 |
| 22 May 2025 | agm | ||
| 22 May 2025 | dividend | ₹5.50 Dividend /Share | 07 Jul 2025 |
| 31 Jan 2025 | dividend | ₹10.50 Dividend /Share | 06 Feb 2025 |
| 06 Jan 2025 | dividend | Interim Dividend - Rs. - 10.5 | 06 Feb 2025 |
Peer Comparison
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Cipla Ltd
Divis Laboratories Ltd
Sun Pharmaceutical Industries Ltd About
Sun Pharmaceuticals Industries is engaged in the business of manufacturing developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients (APIs). The Company has various manufacturing locations spread across the country with trading and other incidental and related activities extending to the global market.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1993
Headquarters
CEO
Dilip S Shanghvi
Employees
Contact
Website
http://www.sunpharma.com
secretarial@sunpharma.com
Phone
91-265-6615500
Location
Sun Pharma Advanced Res.Centre, Tandalja, Vadodara, Gujarat, 390020
Sun Pharmaceutical Industries Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GQG PARTNERS EMERGING MARKETS EQUITY CIT | block | Buy | 1446414 | 1763.9 | 18 Nov 2025 |
| RELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVE | block | Sell | 1446414 | 1763.9 | 18 Nov 2025 |
| GOLDMAN SACHS BANK EUROPE SE - ODI | block | Buy | 148233 | 1631.6 | 09 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE - ODI | block | Sell | 148233 | 1631.6 | 09 Oct 2025 |
| THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 | block | Sell | 309391 | 1672 | 14 Jul 2025 |
| THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849 | block | Buy | 309391 | 1672 | 14 Jul 2025 |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 656286 | 1556.95 | 27 Feb 2024 |
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 656286 | 1556.95 | 27 Feb 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 3253896 | 1382.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES MARKET NEUTRAL TOPS FUND | block | Buy | 127712 | 1382.1 | 25 Jan 2024 |